Showing results (271-280 of 415) with videos related to

Sort By:
Pageof 42
Neurobiology of Aging|March 16, 2015
Heat shock protein defenses in the neocortex and allocortex of the telencephalonJessica M Posimo, Justin N Weilnau, Amanda M Gleixner, et al.
ACS Nano|April 26, 2021
Affinity Capture of p97 with Small-Molecule Ligand Bait Reveals a 3.6 Å Double-Hexamer Cryoelectron Microscopy StructureMd Rejaul Hoq, Frank S Vago, Kunpeng Li, et al.
In Vivo (Athens, Greece)|August 29, 2018
Evaluation of Different Formulations and Routes for the Delivery of the Ionizing Radiation Mitigator GS-Nitroxide (JP4-039)Michael W Epperly, Peter Wipf, Renee Fisher, et al.
In Vivo (Athens, Greece)|July 30, 2010
Small molecule GS-nitroxide ameliorates ionizing irradiation-induced delay in bone wound healing in a novel murine modelAbhay Gokhale, Jean-Claude Rwigema, Michael W Epperly, et al.
Molecular Pharmacology|September 13, 2005
Redox regulation of Cdc25B by cell-active quinolinedionesMarni Brisson, Theresa Nguyen, Peter Wipf, et al.
Molecular Cancer Therapeutics|September 20, 2005
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenograftsNathan T Ihle, Gillian Paine-Murrieta, Margareta I Berggren, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 21, 2013
Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndromeTyler B Tarr, Waqas Malick, Mary Liang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2009
Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1John S Lazo, Celeste E Reese, Andreas Vogt, et al.
Annals of the New York Academy of Sciences|November 11, 2017
Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leadsStephen D Meriney, Tyler B Tarr, Kristine S Ojala, et al.
Epigenetics|October 10, 2019
PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapiesMalabika Sen, Audrey Kindsfather, Ludmila Danilova, et al.
Pageof 42